Stay updated on Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer revision label was updated from Revision: v3.5.4 to Revision: v3.5.5.
    Difference
    0.1%
    Check dated 2026-06-05T00:14:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.4 appears on the page, replacing the previous version. This indicates a platform update rather than any changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-05-21T17:09:42.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.2 to v3.5.3, indicating a newer metadata version; this change does not alter study details or visible content.
    Difference
    0.1%
    Check dated 2026-04-30T08:53:35.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Site version updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T02:02:19.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck to the study's listed conditions.
    Difference
    0.1%
    Check dated 2026-04-01T12:31:22.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T07:12:39.000Z thumbnail image

Stay in the know with updates to Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.